ncRNA name
hsa_circ_0006352
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
Yes
Biomarker application
Prognosis
Upstream regulatory factors
Not available
Downstream target
Not available
Cancer name
Serous Ovarian Cancer
Cancer site
Ovary
Treatment type
Chemotherapy
Drug
Ciaplatin/Paclitaxel
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Up
Number of patients
60
Male patients
Not available
Female patients
Not available
Age range and number
29(<=60)+31(>60)
PMID
Description
Serum circSETDB1 levels are significantly increased in primary chemoresistance patients.
Tissue resource
serum samples from patients with primary serous ovarian cancer
Experiment
qRT-PCR
Institute
the People's Hospital of Zhengzhou University
Country
China
Continent
Asia